![]() ![]() Sino Health and its subsidiaries have a salesforce of over 100 people, among which 85% of them have prior experience working at multinational pharma companies. The RMB multi-hundred million acquisition involves three commercial stage products and a pipeline product under New Drug Applications (NDAs) review by China's National Medical Products Administration (NMPA). 6, 2022 /PRNewswire/ - Nuance Pharma ("Nuance"or the "Company"), a specialty care focused biopharma with late late-stage clinical programs and existing commercial operations, today announced an agreement with Sino Health Pharmaceutical Limited ("Sino Health"), an affiliated company of Yinglian Pharmaceutical Holdings Group Limited, to fully acquire its 100-percent equity shares and its fully-owned subsidiaries Ying Lian Zhuhai and Ying Lian Germany.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |